ArticleJAMA oncology2019

Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma.

Lola-Jade Palmieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.